STAT5B and osteosarcoma: Our results demonstrate an approximately 40% decrease in GH-stimulated STAT5-luciferase reporter gene activity, in osteosarcoma cells treated with the statin, which could be explained by the decrease in pS726/731-STAT5 observed in presence of simvastatin.